Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01895179
Other study ID # PBRC 13017
Secondary ID
Status Completed
Phase N/A
First received July 3, 2013
Last updated March 15, 2018
Start date July 2013
Est. completion date November 2017

Study information

Verified date March 2018
Source Pennington Biomedical Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this pilot study is to find out what eating meals in a short time period early in the day (time-restricted feeding) versus eating meals spread out during the day (grazing) does to the body's ability to control blood sugar and to the health of its blood vessels.

The investigators hypothesize that time-restricted feeding will be more effective at improving glucose tolerance and vascular condition (inflammation and micro- and macro-vascular function) than grazing.


Description:

Each participant will eat according to one of the two eating schedules (grazing or time-restricted feeding) for 5 weeks, have a 7-week washout period, and then eat according to the other eating schedule for 5 weeks. Measurements of glucose homeostasis and vascular condition will be performed before and after a participant follows each eating schedule.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date November 2017
Est. primary completion date November 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 35 Years to 70 Years
Eligibility Inclusion Criteria:

- Are male

- Overweight: Have a body mass index between 25 and 50 kg/m^2 inclusive (a number calculated from height and weight)

- Are 35-70 years of age

- Have a hemoglobin A1C between 5.5 - 6.4% or prior medical indication of prediabetes

- Have a blood sugar level between 140 and 199 mg/dL two hours after drinking a sugary solution (OGTT)

- Have been eating dinner at least 8.5 hours after eating breakfast at least 90% of the time during the past year

- Have not fasted (go for a day without any food) more than 12 days total during the past year

- Be willing to eat most meals at Pennington Biomedical and/or under supervision

- Not eat any food other than that served by Pennington Biomedical

- Not drink any alcohol, juice, or other beverages that have calories other than what is served by Pennington Biomedical

- Keep water and no-calorie drinks like tea or diet soda the same during both of the timed eating periods

- Be willing to eat your meals according to the fixed schedules

Exclusion Criteria:

- Have diabetes or are on anti-diabetes medication

- Have evidence of cardiovascular disease

- Suffer from significant cardiovascular, renal (kidney), cardiac (heart), liver, lung or nervous system disease

- Evidence of significant gastrointestinal issues or surgery that impacts nutrient absorption

- Regularly use medications such as steroids, beta blockers, and adrenergic-stimulating agents

- Are on any regular medicine that has not had the same dose for 1 month or longer

- Have a clinically significant abnormality as measured by a blood test

- Regularly drink alcohol (more than 2 servings per day)

- Have to do any kind of heavy physical activity

- Currently perform overnight shift work more than one day a week

- Are not able to eat only the food served to you by Pennington Biomedical, while in the study

- Are not able to stop drinking alcohol or other drinks with calories (e.g., soda, juice) other than what is served to you by Pennington Biomedical, while in the study

Study Design


Intervention

Other:
Time-Restricted Feeding
Time-restricted feeding is a variant of intermittent fasting that involves eating all of one's calories within a few hours each day (typically 4-9 hours), followed by a daily fast of 15-20 hours.
Grazing
Grazing involves eating meals spread out over the course of the day.

Locations

Country Name City State
United States Pennington Biomedical Research Center Baton Rouge Louisiana

Sponsors (1)

Lead Sponsor Collaborator
Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Glucose Tolerance Glucose tolerance and indices of glucose homeostasis will be determined using an Oral Glucose Tolerance Test (OGTT). Before and after 5 weeks on each feeding schedule
Secondary Change in Vascular Function Macro- and micro-vascular function will be assessed by Radial Artery Applanation Tonometry and by Orthogonal Polarization Spectroscopy. The endpoints measured by these two tests include aortic blood pressure, arterial stiffness, capillary density, and red blood cell velocity. Before and after 5 weeks on each feeding schedule
Secondary Change in Inflammation and Metabolic Markers Serum markers of inflammation, such as C-Reactive Protein (CRP) and inflammatory cytokines, and of metabolic processes will be measured (composite measure). Before and after 5 weeks on each feeding schedule
See also
  Status Clinical Trial Phase
Completed NCT03142633 - MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03383822 - Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Suspended NCT03652987 - Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT04203238 - Potato Research for Enhancing Metabolic Outcomes N/A
Recruiting NCT03658564 - Preoperative Oral Carbohydrate Treatment Minimizes Insulin Resistance N/A
Completed NCT04183257 - Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics Phase 4
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03627104 - Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A
Active, not recruiting NCT03288025 - Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE) N/A
Completed NCT03809182 - Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels. Phase 4
Completed NCT01809288 - Identifying Risk for Diabetes and Heart Disease in Women
Completed NCT04642482 - Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity Phase 4
Terminated NCT03278236 - Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? N/A
Not yet recruiting NCT06159543 - The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes N/A
Withdrawn NCT04741204 - Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer Phase 4
Not yet recruiting NCT05540249 - Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG N/A